[ad_1]
Lucknow:
The Uttar Pradesh Government on Wednesday allowed the phase-Three trial of anti-COVID-19 vaccine “Covaxin” in Lucknow and Gorakhpur.
The vaccine is presently being examined by Bharat Biotech Ltd in collaboration with the Indian Council of Medical Research (ICMR).
Additional Chief Secretary (Medical and Health) Amit Mohan Prasad conveyed the federal government’s permission to check the anti-COVID-19 vaccine within the two cities by means of a letter to Bharat Biotech International Limited’s director V Krishna Mohan.
“Kindly refer to your letter dated September 19, 2020, for permission and facilitation to initiate the COVAXIN Phase 3 Efficacy and Safety clinical trials in Uttar Pradesh. It has been decided to allow Bharat Biotech to conduct Phase-3 trial in Lucknow and Gorakhpur,” Mr Prasad mentioned in his letter.
“All permission will have to be obtained by you and all safety and other protocols will have to be followed as per the guidelines of the Government of India for conducting clinical trials,” he added within the letter.
For Lucknow, Dr RK Dhiman, the director of Sanjay Gandhi Post Graduate Institute of Medical Sciences has been made the nodal particular person, whereas for Gorakhpur, Dr Ganesh Kumar, the Principal of BRD Medical College has been made the nodal officer.
[ad_2]
Source hyperlink